CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 170 filers reported holding CLOVIS ONCOLOGY INC in Q4 2018. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $2,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q4 2018 | $2,000 | -33.3% | 100 | 0.0% | 0.00% | – |
| Q3 2018 | $3,000 | -40.0% | 100 | 0.0% | 0.00% | -100.0% |
| Q2 2018 | $5,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $5,000 | -28.6% | 100 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $7,000 | -12.5% | 100 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $8,000 | -11.1% | 100 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $9,000 | +50.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $6,000 | +50.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $4,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $4,000 | +300.0% | 100 | 0.0% | 0.00% | – |
| Q2 2016 | $1,000 | -50.0% | 100 | 0.0% | 0.00% | – |
| Q1 2016 | $2,000 | -50.0% | 100 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $4,000 | -55.6% | 100 | 0.0% | 0.00% | -50.0% |
| Q3 2015 | $9,000 | -65.4% | 100 | -66.7% | 0.00% | -60.0% |
| Q2 2015 | $26,000 | – | 300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |